Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

Economic Impact of Parkinson's Disease in Europe and Its Implications

Aug 28, 2026 August 28, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

A study published in Movement Disorders reveals that the societal cost of Parkinson's disease in Europe reached €22.8 billion in 2019, projected to rise due to increasing cases. This situation highlights the strain on health systems, which could have implications for countries like Iran facing similar health challenges.

🔍 Quick Context Guide
💡 Bottom Line: The rising costs of Parkinson's disease in Europe signal a growing healthcare challenge that could resonate in Iran and beyond.

👥 Key Players

European Health Authorities MENTIONED
Regulatory and health policy makers
"They are responsible for managing health systems that could face increased pressure from chronic diseases like Parkinson's."
Movement Disorders Journal MENTIONED
Academic publication
"They provide a platform for research that informs health policy and public awareness about diseases."

📰 What Happened

A study published in Movement Disorders highlights that the societal cost of Parkinson's disease in Europe was €22.8 billion in 2019 and is expected to rise. This increase is attributed to the growing number of individuals diagnosed with the disease.

  • The cost is projected to reach €28.8 billion by 2025.
  • The rising prevalence of Parkinson's disease will strain health and social care systems.

💡 Why It Matters

🇮🇷 For Iran: Iran faces similar health challenges with increasing rates of chronic diseases, which could strain its healthcare system.
🌍 Regional: Other countries in the region may also experience rising healthcare costs due to similar health trends.
🌐 International: The findings may prompt international dialogue on healthcare funding and chronic disease management strategies.

📚 Background

Parkinson's disease is a progressive neurological disorder that affects movement and can lead to significant healthcare costs. Understanding its economic impact is crucial for effective health policy.

Chronic disease management Healthcare economics
📡 Source: NEUTRAL
📊 Confidence: 70%
The study is published in a reputable academic journal, indicating a focus on research-based findings.

The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019, equivalent to €28.8 billion at 2025 prices, according to a new study published in Movement Disorders. As the number of people living with Parkinson's disease continues to grow, researchers warn that health and social care systems are likely to face increasing pressure.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →